OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)

Holdings History for DEPOMED INC - NOTE 2.500% 9/0

Investment type: Debt / NOTE 2.500% 9/0

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Principal	Change	Activity %	Price	All Holders
31 Mar 2020		-0.14%	$0	0	-5,000,000	-100%		Q1 2020
31 Dec 2019	0.1%	+0.08%	$3,600,000	5,000,000	+2,900,000	+138%	72.0%	Q4 2019
30 Sep 2019	0.04%	-1.9%	$1,564,000	2,100,000	-45,400,000	-96%	74.48%	Q3 2019
30 Jun 2019	0.67%	+0.9%	$34,360,000	47,500,000	+47,500,000	NEW	72.34%	Q2 2019
31 Mar 2019		-1.2%	$0	0	-47,500,000	-100%		Q1 2019
31 Dec 2018	1.2%	+2.1%	$32,300,000	47,500,000	+47,500,000	NEW	68.0%	Q4 2018
30 Sep 2018		-1.3%	$0	0	-36,000,000	-100%		Q3 2018
30 Jun 2018	0.6%	-0.04%	$29,590,000	36,000,000	-1,000,000	-2.7%	82.19%	Q2 2018
31 Mar 2018	0.58%	-0.15%	$30,249,000	37,000,000	-4,000,000	-9.8%	81.75%	Q1 2018
31 Dec 2017	0.61%	-0.08%	$34,203,000	41,000,000	-3,000,000	-6.8%	83.42%	Q4 2017
30 Sep 2017	0.49%	-0.06%	$32,580,000	44,000,000	-3,500,000	-7.4%	74.05%	Q3 2017
30 Jun 2017	0.69%	+0.73%	$41,919,000	47,500,000	+37,000,000	+352%	88.25%	Q2 2017
31 Mar 2017	0.17%	-0.22%	$9,875,000	10,500,000	-9,500,000	-48%	94.05%	Q1 2017
31 Dec 2016	0.44%	+0.54%	$22,900,000	20,000,000	+20,000,000	NEW	114.5%	Q4 2016

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.